Literature DB >> 11814648

Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1.

Robin A Morton1, Frederick M Kuenzi, Stephen M Fitzjohn, Thomas W Rosahl, David Smith, Hui Zheng, Mark Shearman, Graham L Collingridge, Guy R Seabrook.   

Abstract

Presenilin-1 (PS1) is intimately involved in cleavage of amyloid precursor protein to form beta-amyloid peptides, certain forms of which aggregate in the brains of patients with Alzheimer's disease (AD). The function(s) of PS1 and its precise involvement in the development of cognitive deficits associated with AD are unclear. We have utilised genetically modified mice that under-express PS1 (PS1(+/-) mice) to investigate the role of PS1 in hippocampal synaptic plasticity. Field excitatory postsynaptic responses elicited by baseline stimulation were indistinguishable between PS1(+/-) mice and wild-type controls. Likewise, a measure of short-term plasticity, paired-pulse facilitation, was normal in PS1(+/-) mice. However, long-term potentiation induced by multiple tetanus trains was reduced in PS1(+/-) animals. These results demonstrate that chronic reduction of PS1 activity leads to impaired synaptic plasticity, thus suggesting a role for PS1 in normal cognitive function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11814648     DOI: 10.1016/s0304-3940(01)02512-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  Synaptic plasticity in animal models of early Alzheimer's disease.

Authors:  Michael J Rowan; Igor Klyubin; William K Cullen; Roger Anwyl
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-04-29       Impact factor: 6.237

2.  Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia.

Authors:  Stefan Smesny; Susan Stein; Ingo Willhardt; Jürgen Lasch; Heinrich Sauer
Journal:  J Neural Transm (Vienna)       Date:  2008-06-27       Impact factor: 3.575

3.  Modeling presenilin-dependent familial Alzheimer's disease: emphasis on presenilin substrate-mediated signaling and synaptic function.

Authors:  Angèle T Parent; Gopal Thinakaran
Journal:  Int J Alzheimers Dis       Date:  2010-07-20

4.  Involvement of Notch signaling in hippocampal synaptic plasticity.

Authors:  Yue Wang; Sic L Chan; Lucio Miele; Pamela J Yao; Jennifer Mackes; Donald K Ingram; Mark P Mattson; Katsutoshi Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-09       Impact factor: 11.205

Review 5.  Presenilin transgenic mice as models of Alzheimer's disease.

Authors:  Gregory A Elder; Miguel A Gama Sosa; Rita De Gasperi; Dara L Dickstein; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2009-11-18       Impact factor: 3.270

Review 6.  Physiological roles of amyloid-beta and implications for its removal in Alzheimer's disease.

Authors:  Glenda M Bishop; Stephen R Robinson
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1.

Authors:  Stephen M Fitzjohn; Frederick Kuenzi; Robin A Morton; Thomas W Rosahl; Huw Lewis; David Smith; Guy R Seabrook; Graham L Collingridge
Journal:  Mol Brain       Date:  2010-07-14       Impact factor: 4.041

8.  The Beta Amyloid Dysfunction (BAD) Hypothesis for Alzheimer's Disease.

Authors:  Heinz Hillen
Journal:  Front Neurosci       Date:  2019-11-07       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.